BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2020-01430 Atezolizumab plus 8 Gy single-fraction radiotherapy for advanced, oligoprogressive NSCLC after upfront chemotherapy and anti-PD1 immunotherapy clinical trial drugs phase 2 multicentric A Dr med. Francesco Martucci Istituto Oncologico della Svizzera Italiana Oncology Institute of Southern Switzerland, Bellinzona
Geneva University Hospitals (HUG), Genève
Cantonal Hospital of Graubünden (KSGR), Chur
Comitato etico cantonale Ticino Kantonale Ethikkommission Zürich, Commission Cantonale d'éthique de la recherche Genève (CCER) 14.09.2020 Study has ended
2020-01429 Herpes Simplex Virus Reactivation in Patients with Covid-19 and Acute Respiratory Distress Syndrome personal data/biological material monocentric Alessandro F. Chiesa Ente Ospedaliero Cantonale, Bellinzona
Comitato etico cantonale Ticino 24.06.2020
2020-01428 The Swiss register RePreg networking with European Pregnancy registers in rheumatology: Joint data analysis personal data/biological material monocentric Prof. Frauke Förger Inselspital Bern Inselspital Bern, Bern
Kantonale Ethikkommission Bern 25.01.2023
2020-01427 Conservative vs. surgical treatment of spinal burst fractures – a retrospective outcome analysis personal data/biological material monocentric Prof. Dr. Christoph E. Albers Inselspital - Orthopädie Inselspital, Bern
Kantonale Ethikkommission Bern 07.12.2020
2020-01425 Impact of the COVID-19 pandemic on the delay from symptom onset to first medical contact in patients with acute coronary syndromes undergoing percutaneous coronary intervention non clinical, involving persons monocentric A Dr Nils Perrin Geneva University Hospitals, Geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 17.06.2020
2020-01424 Surgical site infections following spinal surgery with and without implants: Retrospective cohort study to compare management and outcome. personal data/biological material monocentric PD Dr. med. Anna Conen, MSc Kantonsspital Aarau Kantonsspital Aarau, Aarau
Ethikkommission Nordwest- und Zentralschweiz EKNZ 15.06.2020 Study has ended
2020-01422 Amputationsfreies Überleben nach pedalen Bypässen (Limb salvage in pedal bypass) personal data/biological material monocentric PD Dr.med.Vladimir Makaloski Herz- und Gefässchirurgie Herz- und Gefässchirurgie Inselspital Bern, Bern
Kantonale Ethikkommission Bern 27.11.2020 Study has ended
2020-01421 Evaluation of atelectasis formation with electrical impedance tomography during anesthesia for MRI in children non clinical, involving persons monocentric A Dr. med. Thomas Riva Insel Spital, Bern Inselspital, Bern
Kantonale Ethikkommission Bern 29.07.2021 yes Study has ended
2020-01420 Preceding oral anticoagulation (direct oral anticoagulation (DOACS) or Vitamin K antagonists) and/or aniagreggation in ptients with SARS-CoV-2: impact on thromboembolic events and mortality personal data/biological material monocentric Dr. med. Aleksandra Nobile-Skibinski ORBV ORBV, Bellinzona
Comitato etico cantonale Ticino 24.06.2022
2020-01419 Étude rétrospective sur le traitement de l’hallux rigidus sévère par arthroplastie d’interposition (CARTIVA SCI). non clinical, involving persons monocentric A Dr Victor Dubois-Ferrière Service de chirurgie orthopedique et traumatologie de l'appareil moteur / HUG Service de Chirurgie Orthopédique et Traumatologie de l'Appareil Moteur, HUG, Genève
Commission Cantonale d'éthique de la recherche Genève (CCER) 14.09.2021
2020-01418 Ultrasound-enhanced versus conventional catheter-directed thrombolysis for acute intermediate-high-risk pulmonary embolism. clinical trial medical devices multicentric A Professor Salah Dine QANADLI CHUV CHUV, Lausanne
Hopital Riviera Chablais, Rennaz
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 18.05.2021
2020-01415 Double-blind, randomized, crossover drug-drug interaction study between pyrimethamine and metformin in healthy volunteers, aimed to identify potential endogenous biomarkers for the inhibition of renal More ... clinical trial drugs n/a monocentric B Dr Haithem Chtioui Centre Hospitalier Universitaire Vaudois - CHUV Centre Hospitalier Universitaire Vaudois - CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 17.07.2020 Study has ended
2020-01414 CCFZ533A2201 - A partially-blinded, active-controlled, multicenter, randomized study evaluating efficacy, safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) of an anti-CD40 monoclonal More ... clinical trial drugs phase 2 multicentric C Prof. Dr. med. Rudolf Wüthrich Novartis Pharma Schweiz AG Universitätsspital Zürich, Zürich
Inselspital, Universitätsspital Bern, Bern
Kantonale Ethikkommission Zürich Kantonale Ethikkommission Bern 08.09.2020 Study has ended
2020-01413 Total-Body PET/CT – an intra-individual comparison with standard digital PET/CT non clinical, involving persons monocentric A Prof. Dr. med. A. Rominger Inselspital Bern Inselspital, Bern
Kantonale Ethikkommission Bern 29.10.2020 Study has ended
2020-01412 A randomized, double-blind placebo-controlled, Phase 3 study of Debio 1143 in combination with platinum-based chemotherapy and standard fractionation intensity-modulated radiotherapy in patients with More ... clinical trial drugs phase 3 multicentric C Petr Szturz Merck Healthcare KGaA, an affiliate of Merck KGaA, Darmstadt, Germany Centre Hospitalier Universitaire Vaudois, Lausanne
Inselspital, Bern University Hospital, Bern
Hopitaux Universitaires de Geneve, Geneve
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Bern, Commission Cantonale d'éthique de la recherche Genève (CCER) 08.10.2020 Study has ended
2020-01411 Reliability of prognostic scores for surgical decision-making in patients with operatively treated thoracolumbar spine metastases – experience of a single-center multidisciplinary treatment framework personal data/biological material monocentric Dr Barges-Coll Juan CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 30.06.2022
2020-01410 Influence of Food on the Oral Bioavailability of Ladarixin 200 mg Capsule in Healthy Volunteers of Both Sexes. A Single dose (400 mg), Randomized, Open Label, Two-Way Crossover Study clinical trial drugs phase 1 monocentric C MD Milko Radicioni Dompé farmaceutici S.p.A. CROSS Research S.A., Arzo
Comitato etico cantonale Ticino 17.06.2020 Study has ended
2020-01409 Grandparents’ involvement and psychosocial outcomes when a grandchild is diagnosed with cancer: acute and long-term consequences non clinical, involving persons monocentric A Prof. Dr. Gisela Michel University of Lucerne University of Lucerne, Lucerne
Ethikkommission Nordwest- und Zentralschweiz EKNZ 26.08.2020 yes Study has ended
2020-01408 A multi-centre, prospective, non-interventional single-arm
study investigating clinical parameters associated with the
use of once-daily oral semaglutide in a real-world adult
population with type More ...
non clinical, involving persons multicentric A PD Dr. med. Thomas Züger Novo Nordisk A/S Kantonsspital Olten, Olten
Elfenaupraxis, Bern
Gruppenpraxis Weststadt, 4500 Solothurn
Praxis Dr. El-Haschimi, 5400 Baden
Endocrinology, University Hospital Basel, 4031 Basel
Praxis Schöngrund, Rotkre More ...
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche s More ... 19.08.2020 Study has ended
2020-01407 Comparative bioavailability of sitagliptin after single dose of a new modified release formulation versus the marketed formulation Januvia® administered to healthy volunteers under fasting conditions
More ...
clinical trial drugs phase 1 monocentric C Dr. Milko Radicioni DPL Pharma S.p.A. CROSS Research S.A. Phase I Unit, CH-6864 Arzo, Switzerland
Comitato etico cantonale Ticino 17.06.2020 Study has ended